Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia
Cardiomyopathy is a primary cause of death in Friedreich ataxia (FRDA) patients with defective iron-sulfur cluster (ISC) biogenesis due to loss of functional frataxin and in rare patients with functional loss of other ISC biogenesis factors. The mechanistic target of rapamycin (mTOR) and AKT signali...
Main Authors: | Wing-Hang Tong, Hayden Ollivierre, Audrey Noguchi, Manik C. Ghosh, Danielle A. Springer, Tracey A. Rouault |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844022016590 |
Similar Items
-
Epigenetic-based therapies for Friedreich ataxia
by: Chiranjeevi eSandi, et al.
Published: (2014-06-01) -
HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich’s Ataxia
by: Mursal Sherzai, et al.
Published: (2020-06-01) -
Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia
by: Vijayendran Chandran, et al.
Published: (2017-12-01) -
Friedreichs ataxia in a diabetic patient
by: Inna Igorevna Klefortova, et al.
Published: (2010-06-01) -
Friedreich ataxia in a family from Mali, West Africa/Friedreich ataxia in a Malian family
by: Cheick A. K. Cissé, et al.
Published: (2021-05-01)